Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01044212
Other study ID # 29359
Secondary ID
Status Completed
Phase N/A
First received January 5, 2010
Last updated September 21, 2015
Start date November 2009
Est. completion date February 2011

Study information

Verified date September 2015
Source University of Rochester
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.


Description:

See above


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date February 2011
Est. primary completion date February 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria:

- Planning to be admitted to the hospital to undergo minimally-invasive urogynecologic surgery at Strong Memorial Hospital.

Procedures may include:

- robot-assisted laparoscopic sacrocolpopexy

- sacrospinous ligament suspension

- uterosacral ligament suspension/paravaginal defect repair

- colpocleisis

- cystocele repair

Additional procedures may include:

- hysterectomy

- adnexectomy

- culdoplasty

- minimally invasive sling procedure (TVT or TOT)

- periurethral collagen injections

- enterocele repair

Exclusion Criteria:

- Planning to undergo laparotomy.

- Undergoing rectocele or perineocele repair as part of surgery.

- Taking Miralax, laxatives, enemas, or suppositories daily, at the time of enrollment.

- Presence of a colostomy.

- Chronic kidney disease

- Insulin-dependent diabetes mellitus

- Known cardiac disease

- Gastric ulcers

- Difficulty swallowing or esophageal stricture

- Persistent nausea and vomiting

- Signs and symptoms consistent with bowel obstruction

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Intervention

Drug:
Docusate
Docusate 100mg BID
Bowel medications
Docusate 100mg BID Metamucil fiber wafers - 2 wafers daily Miralax 1 packet daily Bisacodyl 1 suppository BID

Locations

Country Name City State
United States University of Rochester Rochester New York

Sponsors (1)

Lead Sponsor Collaborator
University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to First Post-op Bowel Movement The time to first post-operative bowel movement was measured in hours after surgery. Within 1 week of surgery No
Secondary Pain Level Associated With First Postoperative Bowel Movement The pain level experienced with the first post-operative bowel movement was recorded and measured on visual analog score with range 0 to 10 in units on scale. 0 being no pain at all. 10 being worst pain. Within 1 week of surgery No
Secondary Consistency of First Postoperative Bowel Movement The consistency of the first post-operative bowel movement was rated using the Bristol Stool Scale. This is a validated scale that is widely used. It is given to patients as a chart. The chart can be seen here: http://en.wikipedia.org/wiki/Bristol_stool_scale.
The seven types of stool are:
Type 1: Separate hard lumps, like nuts (hard to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces. Entirely liquid
Within 1 week of surgery No
See also
  Status Clinical Trial Phase
Completed NCT02367729 - Efficacy of Ear Neurostimulation for Adolescents With Functional Abdominal Pain N/A